Filter Results:
(61)
Show Results For
- All HBS Web
(237)
- People (2)
- News (61)
- Research (151)
- Multimedia (1)
- Faculty Publications (57)
Show Results For
- All HBS Web
(237)
- People (2)
- News (61)
- Research (151)
- Multimedia (1)
- Faculty Publications (57)
Sort by
- 01 Mar 2017
- News
How Deep Brain Stimulation Could Change Medicine
targeted approach gives Bennet hope that Harmoni can benefit not only people suffering from movement disorders, but also a whole class of psychiatric patients who, until now, had few options beyond prescription drugs to help lessen the... View Details
Keywords: Janelle Nanos
- 23 Jan 2019
- News
The Promise of Personalized Medicine
and a 501(c)(3) called Cure Rare Disease. With the foundation, Horgan is trying to build something radical: A model for personalizing drug development, with the hopes of saving not only his brother but countless others. READ MORE Morrell:... View Details
- 13 Oct 2016
- News
Adding Muscle to the Fight Against Disease
biotech companies—as a function of cost, time, and failure modes—tend to risk pivot on one program, one clinical trial, one outcome,” he observes. “Our company is the leader in mining muscle biology for drug discoveries that translate... View Details
Keywords: Deborah Blagg
- 01 Jun 2010
- News
Health IT at the Bedside
ordered not to eat anything in advance of a test but was still given his usual dose of insulin. At hospitals that have modern IT systems, when food is being withheld for studies, corrected insulin orders are automatically suggested in the... View Details
- 01 Mar 2019
- News
The Blue-Green Revolution
breakthrough finally provides a line of sight to a scalable algae biofuel. The company is already growing algae in outdoor ponds at a test facility near California’s Salton Sea, and Fetzer envisions a day when large pools of algae will be... View Details
- 01 Mar 2017
- News
Alumni Take Cold Calls in New York City
focused on 23andMe, whose sale of genetic testing kits directly to consumers was challenged by the Food & Drug Administration. Quelch, who coauthored the case, is also on the faculty of the Harvard T.H. Chan... View Details
- 01 Dec 2013
- News
Your Own Medicine
drug he has ever taken that directly targets his DMD, a rare degenerative disorder in boys that weakens the body's muscles, usually putting sufferers in wheelchairs in adolescence and shutting down their heart and lungs in their 20s. For... View Details
- 01 Jun 2000
- News
The Business of Biotech
biotechnology. The prospect is exhilarating, but the road to this brave new biotech world has more than a few bumps. With an average time line of ten years required to bring a drug to market - and the potential for failure looming every... View Details
Keywords: Julia Hanna
- 01 Jun 2012
- News
Inspiration Is Not Enough
about building the better mousetrap,” he tells us. “Commercializing the better mousetrap is the key to success.” Take Hugh Hefner. The father of Playboy meets the transformative entrepreneur test by ushering in an era of social freedom... View Details
- 04 Sep 2019
- News
Advancing Diagnostics that Can Save Lives
who spent six years commercializing drugs and diagnostics in East and West Africa before earning her MBA. “There are frequently delays in diagnosis, where the turnaround time for a biopsy could be several weeks or months.” That lag time,... View Details
Keywords: Susan Young
- 01 Dec 2018
- News
Case Study: Your Data, Your Health
otherwise take a decade to diagnose. But NextGen Jane is building more diseases into the pipelines. “There are so many understudied areas in women’s health we could explore,” Tariyal says. Illustration by Marcos Chin The Question: “The first View Details
Keywords: Jen McFarland Flint
- 14 May 2014
- News
(Re)moving the Needle
You wouldn't think that the lowly, annoying mosquito would have anything to teach researchers working on the cutting edge of drug delivery methodology, but you would be wrong. Have you ever noticed that you don't become aware of a... View Details
- 01 Mar 2014
- News
Feedback
bulletin@hbs.edu. Write us a letter. This is your magazine. It needs your voice. Gene Williams, featured in the December 2013 HBS Alumni Bulletin Top Story The story of Gene Williams (MBA 1987) and his new drug development model hit a... View Details
Keywords: Health, Social Assistance
- 01 Dec 2022
- News
Road to Recovery
withdrawal) and other incentives for remaining substance-free and engaging with a treatment program. The company currently offers programs for alcohol, opioids and heroin, and stimulant addiction. Participants can be prompted at random intervals to take an alcohol or... View Details
- 19 Apr 2018
- News
One Last Pitch
app allows the user to participate in random drugs tests using a thumbprint, or breath or saliva tests via video. “No more degrading urine tests,” Gastfriend says. Patients are... View Details
Keywords: Jennifer Myers
- 25 Feb 2020
- News
Alumni and Faculty Books for March 2020
solve our nation's drug epidemic. These accounts, illustrated with searing images by the award-winning photographer Lynsey Addario, provide a picture of working-class families needlessly but profoundly damaged as a result of decades of... View Details
- 01 Sep 2007
- News
Riding It Out
20, 2007, while Gisholt, Minard, and their three young daughters were waiting in line for Test Track, an auto-testing simulation that advises riders to “Strap yourself in to race up bumpy terrain, roar through hairpin turns, speed into... View Details
- 01 Mar 2007
- News
HBS Alums Help Jailhouse Entrepreneurs Go Straight
law-abiding start-up enterprises. The brainchild of former venture capitalist Catherine Rohr, who founded the program in 2004, PEP has seen dozens of participants benefit from its demanding regimen. Multiple interviews and tests are... View Details
- 01 Aug 2001
- News
Cleveland Global Alumni Conference a Sold-Out Success
suggested that the health-care industry is also ripe for disruption. Technological innovations such as improved testing and diagnostic equipment and more targeted drugs could soon break down the existing... View Details
- 25 Jun 2020
- News
Covering All Corners
is coordinating with Gilead Sciences, maker of Remdesivir, to distribute and manufacture the antiviral drug treatment for use in 127 countries, including Egypt. It was recently approved for emergency use by the United States, India,... View Details